NDRA NASDAQ
ENDRA Life Sciences Inc.
1W: +0.3%
1M: -6.2%
3M: +26.5%
YTD: +41.3%
1Y: +5.4%
3Y: -99.7%
5Y: -100.0%
$6.06
+0.18 (+3.06%)
Weekly Expected Move ±11.2%
$5
$5
$6
$7
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (14)
ENDRA Life Sciences (NASDAQ:NDRA) Shares Climb 1.9% – Time to Buy?
ASP Isotopes' Noble Africa unit to merge with ENDRA Life Sciences unit in $50M deal
Analysts Set Expectations for NDRA FY2026 Earnings
Ascendiant Capital Markets Forecasts NDRA Q1 Earnings
Endra Life Sciences GAAP EPS of -$8.93 misses by $2.34
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Large Growth in Short Interest
Why AMTD Digital Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
ENDRA's TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
ENDRA's TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker